The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/grp/volume-2016/5802674/figures/5802674.fig.003a.svgz" name="5802674.fig.003a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Risk of bias graph</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/grp/volume-2016/5802674/figures/5802674.fig.003b.svgz" name="5802674.fig.003b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Risk of bias summary</td></tr></table>

<div>(a) Risk of bias graph: review of authors’ judgments about each risk of bias item presented as percentages across all included RCTs. (b) Risk of bias graph: review of authors’ judgments about each risk of bias item for each included study.</div>

Gastroenterology Research and Practice

fig3

Figure 3

Figure 3: The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis 

Figure 3 | The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis 